[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Sintx Technologies Inc (SINT)

Sintx Technologies Inc (SINT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 7,991
  • Shares Outstanding, K 4,319
  • Annual Sales, $ 1,020 K
  • Annual Income, $ -10,360 K
  • EBIT $ -12 M
  • EBITDA $ -11 M
  • 60-Month Beta 0.63
  • Price/Sales 7.93
  • Price/Cash Flow N/A
  • Price/Book 8.52

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $-0.69
  • Number of Estimates 2
  • High Estimate $-0.56
  • Low Estimate $-0.81
  • Prior Year $-0.91
  • Growth Rate Est. (year over year) +24.18%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.7500 +2.29%
on 07/08/26
2.2450 -20.27%
on 06/12/26
-0.2800 (-13.53%)
since 06/08/26
3-Month
1.7500 +2.29%
on 07/08/26
2.9999 -40.33%
on 04/13/26
-0.9100 (-33.70%)
since 04/08/26
52-Week
1.7500 +2.29%
on 07/08/26
6.7800 -73.60%
on 09/03/25
-1.5200 (-45.92%)
since 07/08/25

Most Recent Stories

More News
SINTX Technologies Announces Receipt of More Than $3.2 Million in Contract Manufacturing Purchase Orders

SALT LAKE CITY, Utah, June 22, 2026 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), a leader in advanced silicon nitride ceramics and advanced material...

SINT : 1.7900 (-3.24%)
SINTX Technologies Announces Raise of Approximately $5.0 Million of Capital, Including a $4.5 Million Private Placement Priced At-the-Market Under Nasdaq Rules

SALT LAKE CITY, Utah, June 03, 2026 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), an advanced biomaterials company focused on developing silicon nitride...

SINT : 1.7900 (-3.24%)
SINTX Technologies to Present at the LD Micro Invitational XVI Conference

Salt Lake City, Utah--(Newsfile Corp. - May 17, 2026) - SINTX Technologies, Inc. (NASDAQ: SINT) ("SINTX" or the "Company"), a medical technology company focused on advanced ceramics and silicon nitride...

SINT : 1.7900 (-3.24%)
SINTX Technologies Provides Corporate Business Update Highlighting First Human Implant, Strategic Transformation, and Commercial Execution

Clinical milestone, new President appointment, and platform expansion position SINTX for commercial rollout and revenue growth in 2026 SALT LAKE CITY, Utah, March 23, 2026 (GLOBE NEWSWIRE) -- SINTX...

SINT : 1.7900 (-3.24%)
SINTX Technologies Announces First-In-Human Surgery Using FDA-Cleared SINAPTIC® Foot & Ankle Implant

Major clinical milestone marks SINTX’s entry into the foot and ankle reconstruction market and advances commercialization of its silicon nitride biomaterial platform SALT LAKE CITY, Utah, March...

SINT : 1.7900 (-3.24%)
SINTX Technologies Appoints Ryan Elmore President to Lead Channel Expansion of Silicon Nitride Biomaterial Platforms

Appointment supports acceleration of revenue opportunities from SiNERGY ™ silicon nitride devices and antipathogenic fibrous material technologies SALT LAKE CITY, Utah, Feb. 18, 2026 (GLOBE...

SINT : 1.7900 (-3.24%)
SINTX Technologies to Participate in Noble Capital Markets’ Emerging Growth Virtual Equity Conference on February 4–5

SALT LAKE CITY, Utah, Jan. 29, 2026 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), an advanced ceramics and biomaterials company focused on silicon-nitride-based...

SINT : 1.7900 (-3.24%)
SINTX Technologies to Participate in Sidoti & Company Investor Conference

SALT LAKE CITY, Utah, Dec. 08, 2025 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), today announced that management will be presenting at Sidoti & Company’s...

SINT : 1.7900 (-3.24%)
SINTX Technologies Signs Supply Agreement with EVONIK to Manufacture Silicon Nitride–PEEK Compound for AI-Assisted, 3D-Printed Patient-Specific Implants

Milestone enables immediate production of SiN/PEEK custom devices SALT LAKE CITY, Utah, Dec. 01, 2025 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”),...

SINT : 1.7900 (-3.24%)
SINTX Reports Pivotal Third Quarter Business Update and Financial Highlights Driven by FDA Clearance, Product and IP Portfolio Expansions and Increased Operational Efficiencies

Company underscores its strengthened liquidity, cost reductions, and first revenue recorded from OsseoSculpt™  SALT LAKE CITY, Utah, Nov. 13, 2025 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc....

SINT : 1.7900 (-3.24%)

Business Summary

SINTX Technologies Inc. is a biomaterials and OEM company. It develops and commercializes silicon nitride for biomedical applications including the spine, dental, oral maxillofacial, podiatry and arthroplasty markets. SINTX Technologies Inc., formerly known as Amedica Corporation, is based in UT, United...

See More

Key Turning Points

3rd Resistance Point 1.9933
2nd Resistance Point 1.9367
1st Resistance Point 1.8633
Last Price 1.7900
1st Support Level 1.7333
2nd Support Level 1.6767
3rd Support Level 1.6033

See More

52-Week High 6.7800
Fibonacci 61.8% 4.8585
Fibonacci 50% 4.2650
Fibonacci 38.2% 3.6715
Last Price 1.7900
52-Week Low 1.7500

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.